Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 89778

2 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
March 21, 2022
Product types
Drug
Classifications
Class I
Statuses
Terminated
Recalling firm wording
Adamis Pharmaceuticals Corporation

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

2 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 2

SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-130-02

D-0763-2022
Recall number
D-0763-2022
Initiated
March 21, 2022
Classification
Class I
Status
Terminated
Quantity
25,103 cartons

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.

Code information

Lot #: 21041W, Exp. 8/31/2022; 21081W, Exp. 11/30/2022; 21102W, Exp. 2/28/2023

Distribution pattern

Nationwide in the U.S.A.

drug · product 2 of 2

SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-131-02.

D-0764-2022
Recall number
D-0764-2022
Initiated
March 21, 2022
Classification
Class I
Status
Terminated
Quantity
2,500 cartons

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.

Code information

Lot # 21101Y, Exp. 11/30/2022

Distribution pattern

Nationwide in the U.S.A.